Acute coronary syndromes -- Did prasugrel & ticagrelor offer same benefits as clopidogrel?

(Bentham Science Publishers) In patients presenting with acute coronary syndromes (ACS) either with or without ST-segment elevation MI (STEMI and NSTEMI), dual antiplatelet therapy (DAPT) is recommended for at least 1 year independently of whether revascularization is performed.